Ali Mortazavi, MD
Clinical Cardiac Electrophysiology · Houston, TXNPI 1295821478
Payments from drug & device makers
Across 165 payments — averaging $93.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Abbott$2K
- Edwards Lifesciences$2K
- Medtronic$730
- Avinger Inc.$24
What the payments were for
- Travel & lodging$3,88859%
- Food & beverage$2,64841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 11 | $10,347 |
| Abbott | 26 | $2,278 |
| Edwards Lifesciences | 122 | $2,015 |
| Medtronic | 5 | $730 |
| Avinger Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOTUS EDGE$1,463
- AMPLATZER AMULET$911
- EVERA MRI XT DR SURESCAN$575
- AMPLATZER TORQVUE 45 X 45$511
- HARMONY$131
- ESPRIT$123
- Mitra Clip system$114
How this compares
$15,394 in reported general payments places this provider in the 25th percentile of 233 clinical cardiac electrophysiology providers in Texas.
See all clinical cardiac electrophysiology providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 331 | $252,209 |
| EntrestoSacubitril/Valsartan | 64 | $53,934 |
| XareltoRivaroxaban | 28 | $28,372 |
| Atorvastatin Calcium | 426 | $13,196 |
| Rosuvastatin Calcium | 211 | $9,379 |
| ClopidogrelClopidogrel Bisulfate | 386 | $8,857 |
| Ezetimibe | 50 | $6,826 |
| Metoprolol Succinate | 263 | $6,520 |
| Carvedilol | 354 | $5,809 |
| Losartan Potassium | 215 | $4,318 |
| Amiodarone Hcl | 153 | $2,958 |
| Metoprolol Tartrate | 292 | $2,870 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 47 | $2,003 |
| Lisinopril | 172 | $1,858 |
| Minocycline Hcl | 193 | $1,546 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Houston
- Miguel ValderrabanoHouston$1.3M
- Ramesh HariharanHouston$793K
- Abdi RasekhHouston$728K
- Amir AzeemHouston$488K
- Mehdi RazaviHouston$390K
- Ilyas ColombowalaHouston$362K
- Ijeoma EkeruoHouston$353K
- John SegerHouston$300K
- Mihail CheluHouston$256K
- Jie ChengHouston$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.